Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Altimmune, Amgen, Beigene, Coherus, JCR, Johnson & Johnson, Novartis, RDIF, Ultragenyx, Verrica.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Algernon, Asklepios, Astrazeneca, Biophytis, Cidara, Eli Lilly, Evgen, Immunic, Inhibikase, Kintara, Mesoblast, Mind Medicine, Moebius, Pfizer, PTC, Redhill, Salarius, Scisparc, Selecta, Silence.
New hires and promotions in the biopharma industry, including: Affinia, Antios, Avadel, Biocardia, Cue, Eli Lilly, Intercept, Maxwell, Scpharmaceuticals.
The latest global regulatory news, changes and updates affecting biopharma in Asia, including: FDA, Fresenius Kabi Oncology, Therapeutic Goods Administration, U.S. Department of Justice.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Astrazeneca, Biontech, China Oncology Focus, Clinuvel, Curevac, Eli Lilly, I-Mab, Immunitybio, Moderna, Nantkwest, Oxford University, Pfizer, Russian Direct Investment Fund, Sorrento, Takeda, Triastek, University of Oxford.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Neurorx, Takeda, Tessa, Turn, University of Oxford.
Biopharmas in Asia-Pacific raising money in public or private financings, including: Adagene, Bionomics, Drug Farm Holding, Medincell, Neox, Neurophth.